Formulation and Drug Delivery, Inhalation Drugs

November 2nd 2023

A novel approach for safety assessments in inhalation drugs may avoid animal testing for drug products.

May 19th 2023

Shabbir Mostafa, head of Business Development — Advanced Delivery Systems, Recipharm, sat down with Grant Playter, associate editor, during DCAT week to discuss the current state of inhalations forms and drug delivery.

March 17th 2023

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.

January 3rd 2023

Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.